HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Featured Stories

AESGP Meeting: Industry Must Be ‘Organized, Bold And Unapologetic’ About Value Of Self-Care

CHPA, CRN Remind US FDA About Enforcement In Comments On NDIN Master File Draft Guidance

Prestige Beauty Boom Not A ‘Short-Term Thing’ – Lauder CEO Fabrizio Freda

Spotlight On Sustainability

Over The Counter: Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta

In this episode of the updated Over The Counter podcast, HBW Insight speaks to sustainable packaging expert Tony Perrotta about the complexities of replacing plastic pill packs in medicines packaging. Perrotta is a partner at PA Consulting, which set up the Blister Pack Collective alongside consumer health players Haleon, Bayer and Sanofi. They are working with PulPac, which has invented a dry molded fiber alternative to plastic, which the Collective hopes to commercialize within 12-24 months. We discuss whether regulators will accept such alternatives, given the safety and stability requirements for medicines, and the challenges of recycling, given the multitude of different frameworks and processes across the world. Perrotta also reveals that one of the partners in PA Consulting’s Bottle Collective, which hopes to replace plastic bottles in the food, personal care and consumer health industries, will soon launch its first market trial.

International Health

Latest Articles

Global Policy, Regulation & Law

NDAC Among US FDA Advisory Committees With Slot Open For Voting Consumer Representative

FDA asks for nominations for voting or non-voting consumer members of its advisory committees. Also wants to hear from consumer organizations interested in participating in selecting consumer representatives for its advisory committees or panels.

AESGP Meeting: Real World Evidence Could Drive Rx-To-OTC Switch, If Regulators Embrace It

Real-world data and evidence, for example generated by digital consumer health technology like apps and wearables, could provide crucial support for Rx-to-OTC switch applications, argues Sanofi Consumer Healthcare’s Penny Glover at the Association of the European Self-Care Industry's 60th Annual Meeting in Brussels, Belgium. Recent research by Sanofi indicates that regulators are actually already using RWD and RWE in many cases when assessing switch applications, even if they do not call it that. 

AESGP Meeting: Medicine Packaging Exemption ‘Not Helpful’ For Circular Economy

Should the consumer health industry be exempt from the EU Packaging and Packaging Waste Directive? This question is hotly debated by representatives from major flexible packaging supplier Amcor and OTC manufacturer Perrigo at the 60th AESGP Annual Meeting in Brussels, Belgium. 

Final US Rule On Destroying Noncompliant Import Devices Amended With Prior Notice To Owners

The US FDA has issued a final rule allowing the agency to destroy some medical devices that have been refused entry into the US. The rule takes effect 1 July.

Digital Health & AI

AESGP Meeting: Real World Evidence Could Drive Rx-To-OTC Switch, If Regulators Embrace It

Real-world data and evidence, for example generated by digital consumer health technology like apps and wearables, could provide crucial support for Rx-to-OTC switch applications, argues Sanofi Consumer Healthcare’s Penny Glover at the Association of the European Self-Care Industry's 60th Annual Meeting in Brussels, Belgium. Recent research by Sanofi indicates that regulators are actually already using RWD and RWE in many cases when assessing switch applications, even if they do not call it that. 

CARU Puts Brands On Notice: Guidelines For Children’s Advertising Extend To AI

The BBB National Programs, Inc.’s Children’s Advertising Review Unit reminds advertisers its Advertising and Privacy Guidelines extend to the use of AI in ads for children and points them to its recent warning that it will ‘strictly enforce’ those guidelines.

AESGP Annual Meeting: OTC Firms Must ‘Innovate Harder’ To Realize Growth Opportunity

Industry can look forward to a global OTC market compound annual growth rate of around 7% over the next few years, according to IQVIA Consumer Health. Innovation will be key to ensure individual companies realize this level of growth. IQVIA CH's Amit Shukla and Simon-Kucher & Partners' Clemens Oberhammer point to some key consumer trends to keep an eye on at the recent AESGP Annual Meeting in Brussels. 

AESGP Meeting: Climate Inaction Could Cost Healthcare Companies 10-20% Operating Profit

Failing to take sufficient action on climate change could be a costly business for consumer health companies. However, the good news from the AESGP's 60th Annual Meeting in Brussels, Belgium, is that at least half of the cost of decarbonizing will be balanced by savings, according to Boston Consulting Group. And climate change adaption will present firms with a wide variety of opportunities for product innovation, IQVIA Consumer Health's Volker Spitzer tells delegates.

See All
Sustainability

Personal Care Is ‘Significant Pillar’ Of US Economy – PCPC’s ‘Beauty Of Impact’ Report

The Personal Care Products Council’s "Beauty of Impact, Economic & Social Contributions Report 2024" illustrates the strength of the US personal-care industry, which added $308.7bn to gross domestic product and accounted for 4.6 million jobs in 2022.

AESGP Annual Meeting: OTC Firms Must ‘Innovate Harder’ To Realize Growth Opportunity

Industry can look forward to a global OTC market compound annual growth rate of around 7% over the next few years, according to IQVIA Consumer Health. Innovation will be key to ensure individual companies realize this level of growth. IQVIA CH's Amit Shukla and Simon-Kucher & Partners' Clemens Oberhammer point to some key consumer trends to keep an eye on at the recent AESGP Annual Meeting in Brussels. 

AESGP Meeting: Climate Inaction Could Cost Healthcare Companies 10-20% Operating Profit

Failing to take sufficient action on climate change could be a costly business for consumer health companies. However, the good news from the AESGP's 60th Annual Meeting in Brussels, Belgium, is that at least half of the cost of decarbonizing will be balanced by savings, according to Boston Consulting Group. And climate change adaption will present firms with a wide variety of opportunities for product innovation, IQVIA Consumer Health's Volker Spitzer tells delegates.

AESGP Meeting: Medicine Packaging Exemption ‘Not Helpful’ For Circular Economy

Should the consumer health industry be exempt from the EU Packaging and Packaging Waste Directive? This question is hotly debated by representatives from major flexible packaging supplier Amcor and OTC manufacturer Perrigo at the 60th AESGP Annual Meeting in Brussels, Belgium. 

See All
Interviews

Digital Health Apps Have Underperformed, But VR Is ‘Very Different’ – Cedars-Sinai Virtual Medicine

Cedars-Sinai’s Virtual Medicine director Brennan Spiegel discusses the shortage of mental health professional resources and how Medical Extended Reality – e.g., immersing patients in a virtual world with an AI therapy avatar – is helping to address depression, pain, and a growing host of health and wellness needs in hospital and consumer settings.

Over The Counter: How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone

In this episode of HBW Insight's Over the Counter podcast, we unpack the Corporate Sustainability Reporting Directive (CSRD) with the help of ESG expert Jasper Crone, drilling down into exactly what consumer health companies need to know about this enormously complex and significant piece of EU legislation.

Get To Know: Fast-Growing, Stigma-Busting, ‘Omnichannel Thinking’ Karo Healthcare

Karo Healthcare has big plans for its expanding range of global OTC brands, the firm reveals in this exclusive Q&A. 

Plastic Packaging: The Search For Alternatives Must Be Pragmatic Not Emotionally Driven

Packaging manufacturer Logoplaste – supplier to major consumer health and cosmetics firms – speaks to HBW Insight about plastics and working with industry to develop alternatives.

See All
Recent Stories

NDAC Among US FDA Advisory Committees With Slot Open For Voting Consumer Representative

FDA asks for nominations for voting or non-voting consumer members of its advisory committees. Also wants to hear from consumer organizations interested in participating in selecting consumer representatives for its advisory committees or panels.

Drug/Cosmetic Uncertainty Clouds CIR Panel Review Of Prostaglandin Analogs

Cosmetic Ingredient Review’s independent expert panel needs more data to assess the safety of prostaglandin analogs, but ultimately may pass review back to the US Food and Drug Administration due to concerns that the substances impact the structure and function of the body and thus are unapproved drugs with potentially serious side effects.

AESGP Meeting: Real World Evidence Could Drive Rx-To-OTC Switch, If Regulators Embrace It

Real-world data and evidence, for example generated by digital consumer health technology like apps and wearables, could provide crucial support for Rx-to-OTC switch applications, argues Sanofi Consumer Healthcare’s Penny Glover at the Association of the European Self-Care Industry's 60th Annual Meeting in Brussels, Belgium. Recent research by Sanofi indicates that regulators are actually already using RWD and RWE in many cases when assessing switch applications, even if they do not call it that. 

Personal Care Is ‘Significant Pillar’ Of US Economy – PCPC’s ‘Beauty Of Impact’ Report

The Personal Care Products Council’s "Beauty of Impact, Economic & Social Contributions Report 2024" illustrates the strength of the US personal-care industry, which added $308.7bn to gross domestic product and accounted for 4.6 million jobs in 2022.

Clear Eyes Production Problems Prestige Consumer Didn’t See Coming Leave Supply On Shelves ‘Spotty’

“Clear Eyes is a perfect example where we're dual-sourced and two facilities don't usually go down at the same time. This was just a quite an anomaly,” says CFO Christine Sacco, noting PCH works with more than 100 contract manufacturers.

Stada Bringing Histamine Intolerance Supplement To US

Germany's Stada has its eyes on expansion in the US dietary supplements market with the launch of histamine intolerance line Histasolv.

Swedish Personalized Supplements Firm Zinzino Targets US Expansion

Personalized dietary supplements firm Zinzino is actively targeting acquisitions in the US to grow its footprint, and is also keeping an eye out for opportunities in Asia Pacific.

Stabilizing Formula Business ‘First And Foremost’ For Perrigo To Reach Sustainable Growth

Perrigo’s adjusted operating income from formula business in 2023 was around half the $140m it expects. Level won’t be reached in 2024 but it’s “well on track to recapturing” that amount in 2025 and to “capturing all of that plus in 2026,” says CEO Patrick Lockwood-Taylor.

CARU Puts Brands On Notice: Guidelines For Children’s Advertising Extend To AI

The BBB National Programs, Inc.’s Children’s Advertising Review Unit reminds advertisers its Advertising and Privacy Guidelines extend to the use of AI in ads for children and points them to its recent warning that it will ‘strictly enforce’ those guidelines.

AESGP Annual Meeting: OTC Firms Must ‘Innovate Harder’ To Realize Growth Opportunity

Industry can look forward to a global OTC market compound annual growth rate of around 7% over the next few years, according to IQVIA Consumer Health. Innovation will be key to ensure individual companies realize this level of growth. IQVIA CH's Amit Shukla and Simon-Kucher & Partners' Clemens Oberhammer point to some key consumer trends to keep an eye on at the recent AESGP Annual Meeting in Brussels. 

NOYZ Intends To Be Heard At Ulta Beauty This Summer

“In an industry that has long been rooted in hyper-filtered fantasy, we saw a massive white space in the fragrance market for a brand rooted in realism,” says NOYZ creator Shaun Neff. The brand is part of a newness infusion aimed at driving Ulta growth amid a broad-based prestige beauty slowdown.

Church & Dwight Atoning For Gummy Vitamin Slump After Punishment From Supply Problems

Executives at recent investor conference offer explanations of what’s happened to sales of the brands in addition to describing the strategies and decisions which have driven company-wide average 6.3% annual net sales growth over the past 10 years.

UsernamePublicRestriction

Register